[
    [
        {
            "time": "2023-10-18",
            "original_text": "UnitedHealthcare to Continue Serving Arizonans Statewide Through the Department of Economic Security Division of Developmental Disabilities Health Plan",
            "features": {
                "keywords": [
                    "UnitedHealthcare",
                    "Arizonans",
                    "Department of Economic Security",
                    "Division of Developmental Disabilities",
                    "Health Plan"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "UnitedHealthcare to Continue Serving Arizonans Statewide Through the Department of Economic Security Division of Developmental Disabilities Health Plan",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "Dow 30 Stock Roundup: WBA Q2 Earnings Disappoint, PFE Lung Cancer Drug Gets EU Approval",
            "features": {
                "keywords": [
                    "Dow 30",
                    "WBA",
                    "Q2 Earnings",
                    "Disappoint",
                    "PFE",
                    "Lung Cancer Drug",
                    "EU Approval"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Dow 30 Stock Roundup: WBA Q2 Earnings Disappoint, PFE Lung Cancer Drug Gets EU Approval",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]